Abstract
Severe acute pancreatitis (SAP) is often associated with pulmonary inflammation leading to acute lung injury. Daphnetin, a natural coumarin derivative, has been reported to exert anti-inflammatory effects. Here, we explored the effect and possible mechanism of daphnetin in a mouse model of SAP-associated lung injury induced by an intraperitoneal injection of l-arginine. The severity of pancreatic and lung injury is determined by histology and its score. Immunostaining of inflammatory and apoptotic cells was used to demonstrate lung tissue inflammation and apoptosis; ELISA analysis of serum and tissue cytokine levels; and western blotting and immunohistochemical staining for the activated Janus kinase 2 (JAK2)–signal transducer and activator of transcription protein 3 (STAT3) signalling pathway in lung tissues. Daphnetin pretreatment significantly reduced SAP-induced pancreatic and lung tissue damage, reduced interleukin-6 and tumour necrosis factor-α concentrations in both serum and lung tissues, reduced serum amylase and myeloperoxidase activities, and reduced macrophage (CD11b) and neutrophil (Ly6G) infiltration and cell apoptosis in the lung tissue. Moreover, SAP-induced phosphorylation of JAK2 and STAT3 in the lung tissue was also significantly diminished by the daphnetin pretreatment. These results indicated that daphnetin reduces SAP-associated lung tissue damage, likely by inhibiting the activation of JAK2–STAT3 signalling.
Similar content being viewed by others
Introduction
Severe acute pancreatitis (SAP) is an inflammatory disease characterized by a complicated aetiology, rapid progression, and poor prognosis1,2. SAP may lead to multiple organ dysfunction, of which SAP-associated acute lung injury (PALI) is the most common complication3. PALI is associated with high morbidity and mortality rates and is responsible for 60% of deaths in the first week after a SAP diagnosis4.
Inflammation plays a well-characterized role in the occurrence and development of PALI. SAP induces the production of pro-inflammatory mediators, including chemokines and cytokines such as interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α), and increases the tissue infiltration and activation of macrophages (CD11b) and neutrophils (Ly6G), leading to pancreatic tissue necrosis5,6. IL-6 regulates the infiltration of neutrophils and promotes inflammation by binding to the IL-6 receptor and activating a signalling pathway involving Janus kinase (JAK) and signal transducer and activator of transcription protein 3 (STAT3)5,6. In the lung, SAP-associated release of pro-inflammatory mediators, excessive endothelial cell damage, and activation of multiple inflammatory pathways lead to increased pulmonary microvascular permeability, resulting in increased penetration of neutrophils into the lungs and perpetuation of the inflammatory cascade8,9. Moreover, the release of numerous inflammatory factors induces the apoptosis of pulmonary microvascular endothelial cells, which results in endothelial barrier dysfunction10. Despite considerable investments in time and effort into understanding the development of PALI, effective treatments are still lacking10. Thus, studies exploring the molecular mechanisms underlying PALI are a great need, thereby enabling the development of novel potential treatments.
The JAK–STAT signalling pathway plays an important role in regulating diverse cellular processes, such as apoptosis, inflammation, and the oxidative stress response11. The pathway is activated by a range of cytokines, growth factors, and proinflammatory mediators11. Engagement of the corresponding receptors induces the phosphorylation and activation of JAK, which then phosphorylates STAT proteins, promoting their translocation to the nucleus and the regulation of target gene transcription12,13. Evidence from many clinical and preclinical studies has suggested that the JAK2–STAT3 pathway plays a pivotal role in lung injury14.
Daphnetin (7,8-dihydroxycoumarin), a natural coumarin derivative, is present in extracts of Daphne odora var. marginata15. Daphnetin possesses numerous pharmacological properties, including analgesic, anti-inflammatory, and anti-oxidant effects, and has been widely used in the clinic to treat diseases such as rheumatoid arthritis, thromboangiitis obliterans, and coronary heart disease16,17,18. Daphnetin has also been suggested to protect rats from acute pancreatitis induced by sodium taurocholate19 and to exert an anti-inflammatory effect on an endotoxin-induced model of lung injury20. It also alleviates acute liver failure by inhibiting NLRP3, MAPK and NF-κB20. Taken together, these observations suggest that daphnetin may be useful for the treatment of PALI.
Here, our study showed that a daphnetin pretreatment reduced SAP-induced pancreatic and lung tissue damage. And we found that the reduction in lung injury might be due to the inhibitory effect of daphnetin on the activation of the JAK2-STAT3 signalling pathway in lung tissue. These findings may partially describe inflammatory responses involved in PALI, which improves our understanding of the pathogenesis and offers potential benefits for disease treatment.
Materials and methods
Reagents
Daphnetin was purchased from Selleck (S2554). The daphnetin preparation used in the present study was 99.23% pure. l-arginine and BCA protein assay kit was purchased from Solarbio Science and Technology (A0013-25g, PC0020). RIPA lysis buffer, phosphatase inhibitor cocktail, and horseradish peroxidase (HRP)-conjugated secondary antibodies were purchased from Beyotime Biotechnology (P0013B, P1081, A0208). Primary antibodies against glyceraldehyde 3-phosphate dehydrogenase (GAPDH), JAK2, and STAT3 were purchased from Proteintech (10494-1-AP, 17670-1-AP, 10253–2-AP), and primary antibodies against the phosphorylated forms of JAK2 and STAT3 (p-JAK2 and p-STAT3) were obtained from Cell Signaling Technology (4406T, 9145T). Serum amylase and lipase enzyme-linked immunosorbent assay (ELISA) kits were purchased from Shanghai Enzyme-linked Biotechnology (ml037819, ml064283). Myeloperoxidase (MPO) ELISA kits were purchased from Cloud Clone (SEA601Mu), and TNF-α and IL-6 ELISA kits were purchased from Proteintech (KE10002, KE10007). Primary antibodies against Ly6G and CD11b, Cy3-conjugated goat anti-rabbit IgG secondary antibody, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) apoptosis detection kit were purchased from Servicebio (GB11229,GB11058,GB21303, G1501).
Animals
Twenty-four male C57BL/6 mice (aged 6–8 weeks and weighing 16–20 g) were purchased from the Animal Experimental Center of Zhengzhou University. All animals were housed under standardized conditions in a controlled environment of 22 °C on a 12 h light–dark cycle and were allowed free access to food and purified water. Experiments were approved by the Ethics Committee of Scientific Research of the First Affiliated Hospital of Zhengzhou University (review number 2019-KY-140) and were conducted in accordance with institutional instructions and regulations.
Animal model of PALI
Mice were fasted (free access to water) for 12 h and then assigned to four groups (n = 6): (1) a control (CON) group (l-arginine vehicle + daphnetin vehicle), (2) SAP group (l-arginine + daphnetin vehicle), (3) DAP group (l-arginine vehicle + daphnetin) and (4) SAP + DAP group (l-arginine + daphnetin).
The SAP model was established by administering two intraperitoneal injections (1 h apart) of l-arginine at a dose of 4 g/kg body weight (diluted in saline, pH 7.0) or the same volume of normal saline (vehicle). Daphnetin was dissolved in 5% dimethyl sulfoxide (DMSO) according to the manufacturer’s instructions, and a dose of 4 mg/kg body weight was administered by intraperitoneal injection 30 min before the injection of l-arginine or vehicle. The SAP group was injected with an equivalent volume of 5% DMSO before the l-arginine injection. After 24 h, the mice were anaesthetized with an intraperitoneal injection of 1% pentobarbital sodium, and blood samples were collected using the orbital venous plexus bleeding method. The blood samples were left undisturbed for 10 min and then centrifuged at 3000 rpm for 10 min at 4 °C. The serum was collected and stored at − 80 °C until analysis. Mice were then sacrificed, and their lungs were removed and divided into two portions: one was stored at − 80 °C and the other was fixed with 4% formaldehyde for subsequent embedding in paraffin and sectioning. The pancreas was removed and fixed with 4% formaldehyde for the histological examination.
Histology
Pancreas and lung tissues were fixed with a 4% paraformaldehyde solution for 2 to 3 days and embedded in paraffin. The blocks were cut into 4-μm sections, stained with haematoxylin and eosin (HE), and evaluated using an optical microscope. Ten random fields (400 × magnification) were selected and evaluated by two experienced pathologists who were blinded to the experimental treatments. The severity of acinar cell injury was evaluated on a semi-quantitative scale based on oedema, inflammatory cell infiltration, and acinar necrosis, as described by Schmidt et al. (1992)22. The severity of lung tissue injury was based on the degree of pulmonary cell edema, hemorrhage, and inflammatory cell infiltration refering to MO, O. et al.23.
ELISA
Serum amylase, serum lipase, serum and lung IL-6, serum and lung TNF-α, and lung MPO levels were determined using specific ELISAs according to the manufacturers’ instructions.
Immunofluorescence staining
The expression of CD11b and Ly6G, which indicate the presence of macrophages and neutrophils respectively, were analysed by immunostaining lung sections. Sections were dewaxed, hydrated, and treated with EDTA-containing antigen retrieval buffer (pH 8.0) in a microwave oven. The tissue was encircled using an immunohistochemical pen and blocked with 5% bovine serum albumin at room temperature. The slides were incubated overnight at 4 °C with primary antibodies against CD11b (1:300) and Ly6G (1:200). After rinses with PBS, the slides were incubated with Cy3-conjugated goat anti-rabbit IgG (H + L) at room temperature in the dark for 50 min. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI). Positive results were quantified using ImageJ software(Image J 2 system software https://imagej.net/Downloads).
TUNEL staining
The TUNEL assay was used to detect apoptotic nuclei in lung sections according to the manufacturer’s instructions. In this assay, nuclei containing fragmented DNA displayed red fluorescence, while normal nuclei emitted the blue fluorescence of DAPI. Positive results were quantified using ImageJ software(Image J 2 system software https://imagej.net/Downloads).
Western blot analysis
Lungs were extracted in RIPA lysis buffer containing a protease/phosphatase inhibitor cocktail and then centrifuged. Protein concentrations in the supernatants were measured using a BCA protein assay kit. Equal amounts of protein (40 μg) from each sample were resolved on 8% SDS-PAGE gels, and proteins were transferred to a 0.45 μm PVDF membrane. The membrane was blocked with 5% skim milk at room temperature for 1 h and then incubated overnight at 4 °C with primary antibodies against GAPDH (1:5000), JAK2 (1:1000), p-JAK2 (1:1000), STAT3 (1:2000), or p-STAT3 (1:2000). The membrane was washed three times for 10 min each with Tris-buffered saline containing 0.05% Tween-20 (TBST) and then incubated with the appropriate HRP-conjugated secondary antibodies (1:5000) for 1 h at room temperature. The membrane was washed again, and bands were revealed by incubating the membrane with the ECL solution in the dark. The blots were analysed using a LI-COR Odyssey Imaging System (LI-COR, Lincoln, NE, USA). The band densities were calculated using ImageJ software(Image J 2 system softwarehttps://imagej.net/Downloads).
Immunohistochemical staining
Paraffin sections (4-μm-thick) were dewaxed with xylene and rehydrated in ethanol. Endogenous peroxidase activity was blocked by incubating sections with 0.3% hydrogen peroxide, and non-specific binding was blocked with normal goat serum for 30 min. The sections were then stained overnight with primary rabbit anti-p-JAK2 or anti-p-STAT3 antibodies, rinsed with PBS, and incubated with the HRP-conjugated secondary antibody for 30 min at room temperature. Colour development was achieved by incubating sections with the HRP substrate 3,5-diaminobenzidine. Positive staining was observed microscopically as brownish-yellow or tan signals, which were quantified using ImageJ software(Image J 2 system software https://imagej.net/Downloads).
Image analysis
The quantitative analysis of western blots, immunohistochemical and immunofluorescence staining were used by ImageJ software(Image J 2 system software https://imagej.net/Downloads. Details about how the imaging program Image J are shown in supplementary material.
Statistical analysis
All analyses were performed using GraphPad Prism 5 software (GraphPad Prism 5.01 http://www.xdowns.com/soft/xdowns2009.asp?softid=49668&downid=60&id=52443). Data are presented as the means ± standard deviations (SD). Histological scores were compared using the Mann–Whitney U test; all other data were analysed using one-way analysis of variance. P < 0.05 was considered significant.
Results
Daphnetin ameliorates pancreatic injury and inflammation in mice with SAP
Four groups of mice (n = 6) were administered the vehicle (CON), l-arginine alone (SAP), l-arginine plus daphnetin (SAP + DAP), or daphnetin alone (DAP). The severity of SAP was assessed by histological scoring of tissue oedema, inflammation, and necrosis. Compared with the CON and DAP mouse groups, the SAP mice displayed pancreatic tissue damage consisting of interstitial oedema, massive neutrophil infiltration, and necrosis (Fig. 1A). Notably, pancreatic injury in mice was significantly reduced by the daphnetin pretreatment (Fig. 1B–E). Serum amylase and lipase concentrations are considered the most sensitive and specific markers of pancreatitis24. Compared with the CON and DAP groups, the SAP group displayed significantly higher serum amylase and lipase levels, but these changes were markedly reduced by the daphnetin treatment (Fig. 1F,G). Serum amylase and lipase levels in the CON and DAP groups were not significantly different. Increases in serum and tissue concentrations of the cytokines TNF-α and IL-6 indicate localized and/or systemic inflammatory responses. Consistent with this finding, TNF-α (Fig. 1H) and IL-6 (Fig. 1I) levels were markedly increased in the SAP group compared with the CON and DAP groups, but the levels were significantly lower in the SAP + DAP group. Based on these results, daphnetin protected against pancreatic injury in the C57BL/6 mouse model of l-arginine-induced SAP.
Daphnetin reduces lung damage and inflammation in mice with PALI
Next, we determined whether daphnetin treatment attenuated PALI. HE staining of the lung tissue from mice in the SAP group revealed severe damage to the alveolar structure, massive neutrophil infiltration, and congestion of the alveolar septal capillaries, but the SAP-induced changes were milder in the SAP + DAP group (Fig. 2A). Accordingly, the lung histopathological score for the SAP + DAP group was significantly lower than that for the SAP group (Fig. 2B).
MPO activity is a marker of neutrophil infiltration, and elevated tissue levels of MPO, TNF-α, and IL-6 are thus indicative of tissue inflammation. Quantification of TNF-α, IL-6, and MPO levels in lung tissue extracts using ELISA revealed that all three inflammatory mediators were present at markedly higher levels in the lungs of mice in the SAP group than in the CON and DAP groups (Fig. 2C–E). Consistent with the histological analyses, significantly lower levels of all three inflammatory markers were detected in the lungs of mice pretreated with daphnetin before SAP induction (Fig. 2C–E). We performed immunofluorescence staining of lung tissue sections to detect macrophages (CD11b) and neutrophils (Ly6G) and to confirm these findings. As expected, the induction of PALI resulted in an increase in the numbers of macrophages and neutrophils in the lung sections, but the increased cell number was attenuated by the daphnetin pretreatment (Fig. 3). These data indicated that daphnetin ameliorated PALI.
Daphnetin inhibits apoptosis in the lungs of mice with PALI
We performed TUNEL staining to determine whether daphnetin protected against PALI-induced apoptosis of lung cells. Indeed, apoptotic cells were more abundant in the lung tissues of mice in the SAP group than in the control groups, but the degree of apoptosis was significantly reduced by the daphnetin pretreatment (Fig. 4, Supplementary Figure S1A). Thus, daphnetin reduced PALI through both anti-inflammatory and anti-apoptotic effects on the lung.
Daphnetin inhibits activation of the JAK2–STAT3 pathway in the lungs of mice with PALI
The JAK–STAT signalling pathway has been widely reported to play an important role in lung injury13,14,15,16,17,18,19,20,21,22,23,24,25. We performed western blot analyses of total and activated (phosphorylated) JAK2 and STAT3 expression in lung extracts to better understand the mechanism by which daphnetin reduces SAP-associated tissue damage in the lung. As shown in Fig. 5A (Full-length blots are presented in Supplementary Figure 2), total JAK2 and STAT3 expression was comparable in lung tissue from mice in the CON, DAP, SAP, and SAP + DAP groups. However, the levels of p-JAK2 and p-STAT3 were increased in the SAP group compared with the control groups, but the increase was attenuated by the daphnetin pretreatment. Accordingly, quantification of the band densities revealed that the ratios of p-JAK2:total JAK2 protein and p-STAT3:total STAT3 protein were significantly lower in the SAP + DAP group than in the SAP group (Fig. 5B,C).
We performed immunohistochemical staining for p-JAK2 and p-STAT3 in lung sections from the four mouse groups to confirm these results. Consistent with the western blot analyses, the expression of p-JAK2 (Fig. 6A,C, Supplementary Figure S1B) and p-STAT3 (Fig. 6B,D) was significantly lower in tissues from the SAP + DAP group than in tissues from the SAP group.
Considering the anti-inflammatory effect of daphnetin on the reduction of systemic inflammation in lung tissue and subsequent effect on JAK2–STAT3 pathway, we chose human lung cells (A549) to conducted an in vitro experiment. The activation of JAK2-STAT3 signalling in LPS-induced lung cells was inhibited by the daphnetin pretreatment, showing that the protective effect of daphnetin on the lung tissue may be mediated by the JAK2-STAT3 signalling pathway (Supplementary Fig. 3,4). Collectively, these results suggest that daphnetin reduces lung damage in mice with PALI probably by inhibiting the activation of the JAK2–STAT3 signalling pathway, thereby reducing the extent of inflammation and cell apoptosis in the lung.
Discussion
The treatment of PALI and other disorders occurring secondary to SAP has been clinically challenging, mainly because the underlying pathophysiological mechanisms are still poorly understood26. Chinese herbs have been widely used in Asia for hundreds of years. However, scientific data to support the clinical efficacy of these traditional Chinese medicines are lacking. Moreover, while previous studies have shown that daphnetin exerts a range of anti-inflammatory effects on acute liver failure26, experimental colitis27, and encephalomyelitis28, little is known about the precise molecular mechanisms that mediate the beneficial effects of daphnetin.
In this study, a PALI mouse model was used to study the effects of daphnetin on the pancreas and lung tissue. Daphnetin reduced not only SAP-associated pancreatic and lung tissue injury but also the accompanying inflammatory response, as evidenced by the levels of tissue and serum markers. Tissue accumulation of macrophages and neutrophils, serum and lung levels of TNF-α and IL-6, and the degree of cell apoptosis were reduced in mice pretreated with daphnetin before SAP induction. In addition, the daphnetin pretreatment inhibited activation of the JAK2–STAT3 pathway in models of lung injury in vivo and in vitro. To our knowledge, this report is the first to show that daphnetin is an effective treatment for pancreatitis-associated lung injury.
Although the pathogenesis of PALI is unknown, dysregulation of the inflammatory response is generally believed to lead to organ damage and death29 by inducing oxidative stress and apoptosis30. Exposure of cells to external stressors stimulates a response involving the release of many inflammatory factors, including TNF-α and IL-6. These cytokines are essential regulators of neutrophil function31, and increased levels are associated with the severity of PALI32. Our findings that daphnetin significantly reduced pancreas and lung tissue injury, inhibited IL-6 and TNF-α production, and decreased MPO activity in mice with SAP are consistent with a previous study by Shen et al. (2017), who showed that daphnetin exerts anti-inflammatory and protective effects on a mouse model of endotoxin-induced lung injury33.
The JAK2–STAT3 pathway plays an indispensable role in cell growth, differentiation, proliferation, and apoptosis34 and mediates the response of cells to cytokines35. Piao et al. (2019) found that inactivation of JAK2 and STAT3 phosphorylation significantly inhibited inflammation and oxidative stress, thereby ameliorating lung tissue damage in a mouse model14. Here, we observed significantly increased phosphorylation of JAK2 and STAT3 in the lungs of mice with SAP, and this change correlated with the effects on serum TNF-α, IL-6, amylase, and lipase levels. Notably, each of these effects was reduced in mice pretreated with daphnetin, consistent with a report by WW et al. (2014) showing that daphnetin protects against lipopolysaccharide-induced lung inflammation and injury in mice36. A similar inhibitory effect of the daphnetin pretreatment on the JAK2-STAT3 pathway was observed in the lung cell injury model. We speculate that JAK2–STAT3 signalling might be a critical intermediary pathway that mediates the anti-inflammatory effect of daphnetin on PALI. Moreover, apoptosis of pulmonary microvascular endothelial cells is presumed to be associated with increases in lung permeability36, and we found that daphnetin reduced cell apoptosis in the lung. However, further mechanistic studies will be necessary to confirm this specific link.
Our study has some limitations. First, we employed an l-arginine-induced model of SAP, and the results should be verified in other SAP models in future experiments. Second, we pretreated the mice with daphnetin before the induction of SAP, which is inconsistent with the clinical situation. The initiation of daphnetin treatment at other time points relative to SAP induction will be examined in future experiments. Finally, many other signalling pathways are involved in PALI, such as the Nrf2 signalling pathway38 and NF-κB signalling pathway. In this study, we justified that daphnetin inhibited the activation of JAK2–STAT3 signalling. We did not clearly determine whether daphnetin influenced other signalling pathways.
In summary, daphnetin preconditioning prior to l-arginine-induced SAP reduces acute lung injury by reducing the infiltration of inflammatory cells and inhibiting inflammatory cytokine secretion and cell apoptosis in the lung tissue. Daphnetin may exert these effects by inhibiting the activation of JAK2-STAT3 signalling, which provides a new perspective for the study of its molecular mechanism.
Statement
The study was carried out in compliance with the ARRIVE guidelines.
References
Li, S. et al. Prophylactic Low-molecular-weight heparin administration protected against severe acute pancreatitis partially by VEGF/Flt-1 signaling in a rat model. Hum. Exp. Toxicol. 1538320682 (2020).
Hou, C. et al. Iguratimod (T-614) Attenuates Severe Acute Pancreatitis by Inhibiting the NLRP3 Inflammasome and NF-κB Pathway. Biomed. Pharmacother. 119, 109455 (2019).
Fang, D. et al. Effects of sildenafil on inflammatory injury of the lung in sodium taurocholate-induced severe acute pancreatitis rats. Int. Immunopharmacol. 80, 106151 (2020).
Piao, X. et al. Picroside II improves severe acute pancreatitis-induced intestinal barrier injury by inactivating oxidative and inflammatory TLR4-dependent PI3K/AKT/NF-κB signaling and improving gut microbiota. Oxid. Med. Cell. Longev. 2020, 1–12 (2020).
De Campos, T., Deree, J. & Coimbra, R. From acute pancreatitis to end-organ injury: mechanisms of acute lung injury. Surg. Infect. 8, 107–120 (2007).
J, G. & D, R. Acute pancreatitis: models, markers, and mediators. Shock (Augusta, Ga.). 45–51 (2005).
Fielding, C. A. et al. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J. Immunol. 1950(181), 2189–2195 (2008).
Wang, H., Li, C., Jiang, Y., Li, H. & Zhang, D. Effects of bacterial translocation and autophagy on acute lung injury induced by severe acute pancreatitis. Gastroent. Res. Pract. 2020, 1–8 (2020).
Xu, C. et al. proteomic analysis reveals the protective effects of emodin on severe acute pancreatitis induced lung injury by inhibiting neutrophil proteases activity. J. Proteom. 220, 103760 (2020).
Gill, S. E., Rohan, M. & Mehta, S. Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo. Resp. Res. 16, 109 (2015).
Zhao, X. et al. Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia–reperfusion-induced kidney injury via the JAK/STAT pathway. Biol. Res. 53, 28 (2020).
Kong, F., Sun, Y., Song, W., Zhou, Y. & Zhu, S. MiR-216a alleviates LPS-induced acute lung injury via regulating JAK2/STAT3 and NF-κB signaling. Hum. Cell 33, 67–78 (2020).
Severgnini, M. et al. Activation of the STAT pathway in acute lung injury. Am. J. Physiol. Lung C 286, L1282–L1292 (2004).
Piao, X. et al. Hydrostatin-SN10 ameliorates pancreatitis-induced lung injury by affecting IL-6-induced JAK2/STAT3-associated inflammation and oxidative stress. Oxid. Med. Cell Longev. 2019, 1–12 (2019).
Yu, W. et al. Daphnetin attenuates microglial activation and proinflammatory factor production via multiple signaling pathways. Int. Immunopharmacol. 21, 1–9 (2014).
Ji, J. et al. Daphnetin ameliorates experimental colitis by modulating microbiota composition and Treg/Th 17 balance. FASEB J. 33, 9308–9322 (2019).
Lv, H. et al. Daphnetin-mediated Nrf2 antioxidant signaling pathways ameliorate tert-butyl hydroperoxide (t-BHP)-induced mitochondrial dysfunction and cell death. Free Radic. Biol. Med. 106, 38–52 (2017).
Liu, Z. et al. Role of Daphnetin in rat severe acute pancreatitis through the regulation of TLR4/NF-κB signaling pathway activation. Am. J. Chin. Med. 44, 149–163 (2016).
Liu, Z. Y. et al. Protective effects of daphnetin on sodium taurocholateinduced severe acute pancreatitis in rats. Mol. Med. Rep. 9, 1709–1714 (2014).
Takahashi, T., Miao, Y., Kang, F., Dolai, S. & Gaisano, H. Y. Susceptibility factors and cellular mechanisms underlying alcoholic pancreatitis. Alcohol. Clin. Exp. Res. 44, 777–789 (2020).
Hongming Lv, X. F. L. W. Daphnetin Alleviates Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure Via the Inhibition of NLRP3, MAPK and NF-κB, and the Induction of Autophagy. (2018).
Schmidt, J. et al. A better model of acute pancreatitis for evaluating therapy. Ann. Surg. 215, 44–56 (1992).
Osman, M. O. et al. A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits. Gut 43, 232–239 (1998).
Zhu, C. et al. Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis. Biomed. Pharmacother. 125, 109919 (2020).
Jiang, Z. Y., Liao, X. C., Zhang, L. & Guo, G. H. Letter to the editor regarding the article “MiR-216a alleviates LPS-induced acute lung injury via regulating JAK2/STAT3 and NF-қB signaling”. Hum. Cell 33, 1329–1330 (2020).
Shields, C. J., Winter, D. C. & Redmond, H. P. Lung injury in acute pancreatitis: mechanisms, prevention, and therapy. Curr. Opin. Crit. Care 8, 158–163 (2002).
Ji, J. et al. Daphnetin ameliorates experimental colitis by modulating microbiota composition and T/T17 balance. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 33, 9308–9322 (2019).
Wang, D. et al. Daphnetin ameliorates experimental autoimmune encephalomyelitis through regulating heme oxygenase-1. Neurochem. Res. 45, 872–881 (2020).
Meng, Y., Sha, S., Yang, J. & Ren, H. Effects of tec tyrosine kinase inhibition on the inflammatory response of severe acute pancreatitis-associated acute lung injury in mice. Digest. Dis. Sci. 64, 2167–2176 (2019).
Zhou, J. et al. Abdominal paracentesis drainage protects rats against severe acute pancreatitis-associated lung injury by reducing the mobilization of intestinal XDH/XOD. Free Radic. Biol. Med. 99, 374–384 (2016).
Liu, Y. et al. Resolvin D1 protects against inflammation in experimental acute pancreatitis and associated lung injury. Am. J. Physiol. Gastrointest. Liver Physiol. 310, G303–G309 (2016).
Ohkawara, T., Takeda, H. & Nishihira, J. Protective effect of chlorogenic acid on the inflammatory damage of pancreas and lung in mice with L-arginine-induced pancreatitis. Life Sci. 190, 91–96 (2017).
Shen, L. et al. Daphnetin reduces endotoxin lethality in mice and decreases LPS-induced inflammation in Raw264.7 cells via suppressing JAK/STATs activation and ROS production. Inflamm. Res. 66, 579–589 (2017).
Yin, Q. et al. JLX001 improves myocardial Ischemia-reperfusion injury by activating Jak2-Stat3 pathway. Life Sci. 257, 118083 (2020).
Li, S. et al. RUNX3 protects against acute lung injury by inhibiting the JAK2/STAT3 pathway in rats with severe acute pancreatitis. Eur. Rev. Med. Pharmaco. 23, 5382 (2019).
Yu, W. W. et al. Anti-inflammatory and protective properties of daphnetin in endotoxin-induced lung injury. J. Agric. Food Chem. 62, 12315–12325 (2014).
Shi, Z. et al. LipoxinA4 attenuates acute pancreatitis-associated acute lung injury by regulating AQP-5 and MMP-9 expression, anti-apoptosis and PKC/SSeCKS-mediated F-actin activation. Mol. Immunol. 103, 78–88 (2018).
Mei, Q. et al. Porous COS@SiO nanocomposites ameliorate severe acute pancreatitis and associated lung injury by regulating the Nrf2 signaling pathway in mice. Front. Chem. 8, 720 (2020).
Acknowledgements
We thank Liwen Bianji and American Journal Experts for editing the English text of a draft of this manuscript.
Funding
This work was supported by grants from the Key Research Projects of Henan Higher Education Institutions (No.20A320018) and Science and Technology Project of Henan Province (No.212102310631).
Author information
Authors and Affiliations
Contributions
#Joint first author: S.Y. and Y.S. contribute equally to this study. C.Z., S.Y., Y.S., and Q.W. contributed to study concept and design. S.Y., Y.S., Y.L., and Z.W. performed the study. S.Y. and Y.S. drafted the manuscript. Z.W., X.D., and Y.Z. performed statistical analysis. C.Z., X.B., Y.G., and S.C. revised the manuscript. All authors participated in and provided help to the study. All authors approved the submitted version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yang, S., Song, Y., Wang, Q. et al. Daphnetin ameliorates acute lung injury in mice with severe acute pancreatitis by inhibiting the JAK2–STAT3 pathway. Sci Rep 11, 11491 (2021). https://doi.org/10.1038/s41598-021-91008-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-91008-6
This article is cited by
-
Dysregulated B7H4/JAK2/STAT3 Pathway Involves in Hypertriglyceridemia Acute Pancreatitis and Is Attenuated by Baicalin
Digestive Diseases and Sciences (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.